Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Vachier (Montpellier, France). Exploitation of anti-inflammatory mechanisms for the treatment of severe asthma. Annual Congress 2005 - Mechanisms of resolution of inflammation

Member's Comments

No comment yet.

Related content which might interest you: Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD Source: Annual Congress 2005 - Protease-antiprotease revisited Year: 2005 Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Biological and therapeutic implications of the united airways disease concept Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005 The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Role of anti-inflammatory treatments in complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Endogenous lipid mediators in the resolution of airway inflammation Source: Eur Respir J 2007; 30: 980-992 Year: 2007 Conclusion: clinical phenotypes of asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Evaluation and management of difficult-to-control asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Characteristics, definition and phenotypes of severe asthma Source: Eur Respir Mon 2011; 51: 50-58 Year: 2011 Beyond corticosteroids: future prospects in the management of inflammation in COPD Source: Eur Respir Rev 2011; 20: 175-182 Year: 2011 Severe asthma: from inflammatory phenotype to treatment Source: International Congress 2017 – Chinese Programme 2017 Year: 2017 Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 COPD: inflammatory mechanisms and systemic consequences Source: Eur Respir Mon 2013; 59: 13-27 Year: 2013 Treatment of severe childhood asthma: what’s the evidence? Source: Annual Congress 2005 - Difficult asthma in children Year: 2005 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Development of new treatments for complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006